
Editors’ Picks, February 2025: Improving CAR T, Studying Breast Cancer Risk, and More
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
As World Cancer Day 2025 focuses on being "United by Unique," AACR shares how its initiatives help to connect...
This quarterly series on creative approaches to cancer research includes urine-powered nanomotors, unique molds to grow organoids, and more.
As winter marches on, let’s dive into the cool articles highlighted this month by the editors of the AACR...
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
This month, the editors of the AACR journals highlighted studies about the gut microbiome in lung cancer, modeling the...
What did we learn about cancer in 2024? How did research advance our understanding of cancer? What new approvals...
As we head into the holiday season, Cancer Research Catalyst has tantalizing teasers in the form of science stocking...
This month, the editors selected studies comparing CAR T therapies for large B-cell lymphoma, assessing a new type of...
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...